ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,987Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 448

$1.03M Total Retail Price of All Prescriptions

Rank: 22 out of 448

882 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 882 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 11,959 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $111 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 626 470 1 1
SIMVASTATIN 626 495 1 4
BENAZEPRIL HCL 576 444 3 38
METFORMIN HCL 486 365 4 2
CARVEDILOL 456 377 5 36
FUROSEMIDE 390 356 6 25
ALENDRONATE SODIUM 374 342 7 17
GLIPIZIDE 336 271 8 15
AMLODIPINE BESYLATE 326 265 9 12
OMEPRAZOLE 319 252 10 21
INSULIN SYRINGE 296 221 11 9
HYDROCHLOROTHIAZIDE 284 219 12 27
ATORVASTATIN CALCIUM 270 218 13 13
METOPROLOL TARTRATE 238 154 14 44
DIOVAN 238 190 14 23
HYDROCODONE-ACETAMINOPHEN 221 183 S3 16 33
NOVOLOG MIX 70-30 221 159 16 82
LOSARTAN POTASSIUM 219 199 18 16
GABAPENTIN 214 163 19 30
TAMSULOSIN HCL 187 185 20 46
LISINOPRIL 182 145 21 14
LANTUS 174 108 22 8
LOVASTATIN 161 141 23 40
RANITIDINE HCL 154 130 24 115
WARFARIN SODIUM 149 121 25 53
ATENOLOL 143 125 26 29
NIFEDIPINE ER 142 122 27 130
SPIRIVA 141 113 28 158
SERTRALINE HCL 137 127 29 93
IBUPROFEN 137 113 29 79
LIPITOR 132 102 31 56
ZOLPIDEM TARTRATE 124 109 32 37
PRAVASTATIN SODIUM 120 91 33 31
GLYBURIDE 115 91 R 34 42
ACTOS 108 86 35 20
HUMALOG 106 73 36 11
NAPROXEN 105 77 37 133
PROAIR HFA 104 58 38 121
PEN NEEDLE 102 64 39 5
ADVAIR DISKUS 99 80 40 112
HUMALOG MIX 75-25 95 73 41 45
ACETAMINOPHEN-CODEINE 95 89 S3 41 183
TRAMADOL HCL 87 62 43 67
PANTOPRAZOLE SODIUM 84 59 44 62
CLOPIDOGREL 82 72 45 71
DILTIAZEM ER 82 75 45 224
PLAVIX 80 70 47 75
ENALAPRIL MALEATE 79 58 48 81
HYDRALAZINE HCL 77 59 49 118
CLONIDINE HCL 75 57 50 72
SPIRONOLACTONE 75 74 50 110
ALLOPURINOL 74 67 52 48
JANUVIA 74 63 52 6
NIFEDICAL XL 68 56 54 240
METOPROLOL SUCCINATE 66 59 55 39
DONEPEZIL HCL 66 66 55 68
ISOSORBIDE MONONITRATE ER 65 63 57 108
DIGOXIN 63 60 58 120
FINASTERIDE 63 63 58 136
XOPENEX HFA 62 57 60 282
NEXIUM 59 58 61 63
DIOVAN HCT 58 43 62 61
PREDNISONE 57 42 63 139
MELOXICAM 56 50 64 65
TRIAMCINOLONE ACETONIDE 55 44 65 109
NAMENDA 53 53 66 86
NOVOLOG 53 38 66 34
DILTIAZEM 24HR CD 53 45 66 179
CRESTOR 53 41 66 22
FLUTICASONE PROPIONATE 52 46 70 88
LOSARTAN-HYDROCHLOROTHIAZIDE 52 47 70 50
VESICARE 50 40 72 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.